Search For

On the potential of group-specific component (GC) inhibition for treating metabolic disease

Novel insights into the purinergic P2X7 receptor signaling in obesity and cardiovascular-kidney-metabolic syndrome: a brief overview

Will a “multivitamin” a day keep the “MASLD doctor” away?

Lipid metabolism in liver transplantation: from challenge to chance

Fatty liver disease in the pediatric population: history, definitions, and challenges in nomenclature (NAFLD/MAFLD/MASLD)

Shared genetic architecture between metabolic dysfunction-associated steatotic liver disease and cardiometabolic traits comorbidities: a genome-wide pleiotropic and multi-omics study

Metabolism, sex, and what lies beyond the scalpel in MASLD

Metrnl plays a crucial role in the regulation of glycolipid metabolism

Artificial intelligence in cardiac metabolism: the next frontier in cardiovascular health

Role of skin enzymes in metabolism of topical drugs

Dysregulation of sphingolipid metabolism in liver fibrosis

Lower hepatic CBS and PEMT expression in advanced NAFLD: inferencing strategies to lower homocysteine with a mathematical model